 | • レポートコード：QY2207C0369 • 出版社/出版日：QYResearch / 2022年7月15日 • レポート形態：英文、PDF、91ページ • 納品方法：Eメール（納期：3日） • 産業分類：化学＆材料 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Multi User | ￥1,087,800 (USD7,350) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症のパンデミックにより、世界のフェロジピンの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にフェロジピンの世界市場のxxx％を占める「純度98％」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「降圧薬」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 中国のフェロジピンの市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパのフェロジピン市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパのフェロジピン市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 フェロジピンのグローバル主要メーカーには、Jinan Kehui Pharmaceutical Technology、Wockhardt、HEC Pharm、Hefei Lifeon Pharmaceutical、Jiangsu Lianhuan Pharmaceuticalなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 フェロジピン市場は、種類と用途によって区分されます。世界のフェロジピン市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 純度98％、純度99％ 【用途別セグメント】 降圧薬、有機合成、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - フェロジピン製品概要 - 種類別市場（純度98％、純度99％） - 用途別市場（降圧薬、有機合成、その他） - 調査の目的 ・エグゼクティブサマリー - 世界のフェロジピン販売量予測2017-2028 - 世界のフェロジピン売上予測2017-2028 - フェロジピンの地域別販売量 - フェロジピンの地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別フェロジピン販売量 - 主要メーカー別フェロジピン売上 - 主要メーカー別フェロジピン価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（純度98％、純度99％） - フェロジピンの種類別販売量 - フェロジピンの種類別売上 - フェロジピンの種類別価格 ・用途別市場規模（降圧薬、有機合成、その他） - フェロジピンの用途別販売量 - フェロジピンの用途別売上 - フェロジピンの用途別価格 ・北米市場 - 北米のフェロジピン市場規模（種類別、用途別） - 主要国別のフェロジピン市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパのフェロジピン市場規模（種類別、用途別） - 主要国別のフェロジピン市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋のフェロジピン市場規模（種類別、用途別） - 主要国別のフェロジピン市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米のフェロジピン市場規模（種類別、用途別） - 主要国別のフェロジピン市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカのフェロジピン市場規模（種類別、用途別） - 主要国別のフェロジピン市場規模（トルコ、サウジアラビア） ・企業情報 Jinan Kehui Pharmaceutical Technology、Wockhardt、HEC Pharm、Hefei Lifeon Pharmaceutical、Jiangsu Lianhuan Pharmaceutical ・産業チェーン及び販売チャネル分析 - フェロジピンの産業チェーン分析 - フェロジピンの原材料 - フェロジピンの生産プロセス - フェロジピンの販売及びマーケティング - フェロジピンの主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - フェロジピンの産業動向 - フェロジピンのマーケットドライバー - フェロジピンの課題 - フェロジピンの阻害要因 ・主な調査結果 |
Market Analysis and Insights: Global Felodipine Market
Due to the COVID-19 pandemic, the global Felodipine market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, 98% Purity accounting for % of the Felodipine global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Antihypertensive Drugs segment is altered to an % CAGR throughout this forecast period.
China Felodipine market size is valued at US$ million in 2021, while the US and Europe Felodipine are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Felodipine landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Felodipine include Jinan Kehui Pharmaceutical Technology, Wockhardt, HEC Pharm, Hefei Lifeon Pharmaceutical and Jiangsu Lianhuan Pharmaceutical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
In terms of production side, this report researches the Felodipine capacity, production, growth rate, market share by manufacturers and by region (region level and country level), from 2017 to 2022, and forecast to 2028.
In terms of sales side, this report focuses on the sales of Felodipine by region (region level and country level), by company, by Type and by Application. from 2017 to 2022 and forecast to 2028.
Global Felodipine Scope and Segment
Felodipine market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Felodipine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
98% Purity
99% Purity
Segment by Application
Antihypertensive Drugs
Organic Synthesis
Other
By Company
Jinan Kehui Pharmaceutical Technology
Wockhardt
HEC Pharm
Hefei Lifeon Pharmaceutical
Jiangsu Lianhuan Pharmaceutical
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
1 Study Coverage
1.1 Felodipine Product Introduction
1.2 Market by Type
1.2.1 Global Felodipine Market Size by Type, 2017 VS 2021 VS 2028
1.2.2 98% Purity
1.2.3 99% Purity
1.3 Market by Application
1.3.1 Global Felodipine Market Size by Application, 2017 VS 2021 VS 2028
1.3.2 Antihypertensive Drugs
1.3.3 Organic Synthesis
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Felodipine Production
2.1 Global Felodipine Production Capacity (2017-2028)
2.2 Global Felodipine Production by Region: 2017 VS 2021 VS 2028
2.3 Global Felodipine Production by Region
2.3.1 Global Felodipine Historic Production by Region (2017-2022)
2.3.2 Global Felodipine Forecasted Production by Region (2023-2028)
2.4 North America
2.5 Europe
2.6 China
2.7 Japan
3 Global Felodipine Sales in Volume & Value Estimates and Forecasts
3.1 Global Felodipine Sales Estimates and Forecasts 2017-2028
3.2 Global Felodipine Revenue Estimates and Forecasts 2017-2028
3.3 Global Felodipine Revenue by Region: 2017 VS 2021 VS 2028
3.4 Global Felodipine Sales by Region
3.4.1 Global Felodipine Sales by Region (2017-2022)
3.4.2 Global Sales Felodipine by Region (2023-2028)
3.5 Global Felodipine Revenue by Region
3.5.1 Global Felodipine Revenue by Region (2017-2022)
3.5.2 Global Felodipine Revenue by Region (2023-2028)
3.6 North America
3.7 Europe
3.8 Asia-Pacific
3.9 Latin America
3.10 Middle East & Africa
4 Competition by Manufactures
4.1 Global Felodipine Production Capacity by Manufacturers
4.2 Global Felodipine Sales by Manufacturers
4.2.1 Global Felodipine Sales by Manufacturers (2017-2022)
4.2.2 Global Felodipine Sales Market Share by Manufacturers (2017-2022)
4.2.3 Global Top 10 and Top 5 Largest Manufacturers of Felodipine in 2021
4.3 Global Felodipine Revenue by Manufacturers
4.3.1 Global Felodipine Revenue by Manufacturers (2017-2022)
4.3.2 Global Felodipine Revenue Market Share by Manufacturers (2017-2022)
4.3.3 Global Top 10 and Top 5 Companies by Felodipine Revenue in 2021
4.4 Global Felodipine Sales Price by Manufacturers
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global Felodipine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5.3 Global Felodipine Manufacturers Geographical Distribution
4.6 Mergers & Acquisitions, Expansion Plans
5 Market Size by Type
5.1 Global Felodipine Sales by Type
5.1.1 Global Felodipine Historical Sales by Type (2017-2022)
5.1.2 Global Felodipine Forecasted Sales by Type (2023-2028)
5.1.3 Global Felodipine Sales Market Share by Type (2017-2028)
5.2 Global Felodipine Revenue by Type
5.2.1 Global Felodipine Historical Revenue by Type (2017-2022)
5.2.2 Global Felodipine Forecasted Revenue by Type (2023-2028)
5.2.3 Global Felodipine Revenue Market Share by Type (2017-2028)
5.3 Global Felodipine Price by Type
5.3.1 Global Felodipine Price by Type (2017-2022)
5.3.2 Global Felodipine Price Forecast by Type (2023-2028)
6 Market Size by Application
6.1 Global Felodipine Sales by Application
6.1.1 Global Felodipine Historical Sales by Application (2017-2022)
6.1.2 Global Felodipine Forecasted Sales by Application (2023-2028)
6.1.3 Global Felodipine Sales Market Share by Application (2017-2028)
6.2 Global Felodipine Revenue by Application
6.2.1 Global Felodipine Historical Revenue by Application (2017-2022)
6.2.2 Global Felodipine Forecasted Revenue by Application (2023-2028)
6.2.3 Global Felodipine Revenue Market Share by Application (2017-2028)
6.3 Global Felodipine Price by Application
6.3.1 Global Felodipine Price by Application (2017-2022)
6.3.2 Global Felodipine Price Forecast by Application (2023-2028)
7 North America
7.1 North America Felodipine Market Size by Type
7.1.1 North America Felodipine Sales by Type (2017-2028)
7.1.2 North America Felodipine Revenue by Type (2017-2028)
7.2 North America Felodipine Market Size by Application
7.2.1 North America Felodipine Sales by Application (2017-2028)
7.2.2 North America Felodipine Revenue by Application (2017-2028)
7.3 North America Felodipine Sales by Country
7.3.1 North America Felodipine Sales by Country (2017-2028)
7.3.2 North America Felodipine Revenue by Country (2017-2028)
7.3.3 United States
7.3.4 Canada
8 Europe
8.1 Europe Felodipine Market Size by Type
8.1.1 Europe Felodipine Sales by Type (2017-2028)
8.1.2 Europe Felodipine Revenue by Type (2017-2028)
8.2 Europe Felodipine Market Size by Application
8.2.1 Europe Felodipine Sales by Application (2017-2028)
8.2.2 Europe Felodipine Revenue by Application (2017-2028)
8.3 Europe Felodipine Sales by Country
8.3.1 Europe Felodipine Sales by Country (2017-2028)
8.3.2 Europe Felodipine Revenue by Country (2017-2028)
8.3.3 Germany
8.3.4 France
8.3.5 U.K.
8.3.6 Italy
8.3.7 Russia
9 Asia Pacific
9.1 Asia Pacific Felodipine Market Size by Type
9.1.1 Asia Pacific Felodipine Sales by Type (2017-2028)
9.1.2 Asia Pacific Felodipine Revenue by Type (2017-2028)
9.2 Asia Pacific Felodipine Market Size by Application
9.2.1 Asia Pacific Felodipine Sales by Application (2017-2028)
9.2.2 Asia Pacific Felodipine Revenue by Application (2017-2028)
9.3 Asia Pacific Felodipine Sales by Region
9.3.1 Asia Pacific Felodipine Sales by Region (2017-2028)
9.3.2 Asia Pacific Felodipine Revenue by Region (2017-2028)
9.3.3 China
9.3.4 Japan
9.3.5 South Korea
9.3.6 India
9.3.7 Australia
9.3.8 Taiwan
9.3.9 Indonesia
9.3.10 Thailand
9.3.11 Malaysia
10 Latin America
10.1 Latin America Felodipine Market Size by Type
10.1.1 Latin America Felodipine Sales by Type (2017-2028)
10.1.2 Latin America Felodipine Revenue by Type (2017-2028)
10.2 Latin America Felodipine Market Size by Application
10.2.1 Latin America Felodipine Sales by Application (2017-2028)
10.2.2 Latin America Felodipine Revenue by Application (2017-2028)
10.3 Latin America Felodipine Sales by Country
10.3.1 Latin America Felodipine Sales by Country (2017-2028)
10.3.2 Latin America Felodipine Revenue by Country (2017-2028)
10.3.3 Mexico
10.3.4 Brazil
10.3.5 Argentina
10.3.6 Colombia
11 Middle East and Africa
11.1 Middle East and Africa Felodipine Market Size by Type
11.1.1 Middle East and Africa Felodipine Sales by Type (2017-2028)
11.1.2 Middle East and Africa Felodipine Revenue by Type (2017-2028)
11.2 Middle East and Africa Felodipine Market Size by Application
11.2.1 Middle East and Africa Felodipine Sales by Application (2017-2028)
11.2.2 Middle East and Africa Felodipine Revenue by Application (2017-2028)
11.3 Middle East and Africa Felodipine Sales by Country
11.3.1 Middle East and Africa Felodipine Sales by Country (2017-2028)
11.3.2 Middle East and Africa Felodipine Revenue by Country (2017-2028)
11.3.3 Turkey
11.3.4 Saudi Arabia
11.3.5 UAE
12 Corporate Profiles
12.1 Jinan Kehui Pharmaceutical Technology
12.1.1 Jinan Kehui Pharmaceutical Technology Corporation Information
12.1.2 Jinan Kehui Pharmaceutical Technology Overview
12.1.3 Jinan Kehui Pharmaceutical Technology Felodipine Sales, Price, Revenue and Gross Margin (2017-2022)
12.1.4 Jinan Kehui Pharmaceutical Technology Felodipine Product Model Numbers, Pictures, Descriptions and Specifications
12.1.5 Jinan Kehui Pharmaceutical Technology Recent Developments
12.2 Wockhardt
12.2.1 Wockhardt Corporation Information
12.2.2 Wockhardt Overview
12.2.3 Wockhardt Felodipine Sales, Price, Revenue and Gross Margin (2017-2022)
12.2.4 Wockhardt Felodipine Product Model Numbers, Pictures, Descriptions and Specifications
12.2.5 Wockhardt Recent Developments
12.3 HEC Pharm
12.3.1 HEC Pharm Corporation Information
12.3.2 HEC Pharm Overview
12.3.3 HEC Pharm Felodipine Sales, Price, Revenue and Gross Margin (2017-2022)
12.3.4 HEC Pharm Felodipine Product Model Numbers, Pictures, Descriptions and Specifications
12.3.5 HEC Pharm Recent Developments
12.4 Hefei Lifeon Pharmaceutical
12.4.1 Hefei Lifeon Pharmaceutical Corporation Information
12.4.2 Hefei Lifeon Pharmaceutical Overview
12.4.3 Hefei Lifeon Pharmaceutical Felodipine Sales, Price, Revenue and Gross Margin (2017-2022)
12.4.4 Hefei Lifeon Pharmaceutical Felodipine Product Model Numbers, Pictures, Descriptions and Specifications
12.4.5 Hefei Lifeon Pharmaceutical Recent Developments
12.5 Jiangsu Lianhuan Pharmaceutical
12.5.1 Jiangsu Lianhuan Pharmaceutical Corporation Information
12.5.2 Jiangsu Lianhuan Pharmaceutical Overview
12.5.3 Jiangsu Lianhuan Pharmaceutical Felodipine Sales, Price, Revenue and Gross Margin (2017-2022)
12.5.4 Jiangsu Lianhuan Pharmaceutical Felodipine Product Model Numbers, Pictures, Descriptions and Specifications
12.5.5 Jiangsu Lianhuan Pharmaceutical Recent Developments
13 Industry Chain and Sales Channels Analysis
13.1 Felodipine Industry Chain Analysis
13.2 Felodipine Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 Felodipine Production Mode & Process
13.4 Felodipine Sales and Marketing
13.4.1 Felodipine Sales Channels
13.4.2 Felodipine Distributors
13.5 Felodipine Customers
14 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
14.1 Felodipine Industry Trends
14.2 Felodipine Market Drivers
14.3 Felodipine Market Challenges
14.4 Felodipine Market Restraints
15 Key Finding in The Global Felodipine Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer